Evidence map›Paper›PMID 41725505›Full record

ArticleJournal of neurochemistry2026

CASPR2 Autoimmune Antibodies Induce Neuronal Hyperactivity in Human Brain Organoids.

Ana Rafaela Oliveira, Giuseppe Cammarata, Catarina Seabra, Ana Maria Cardoso, Henrique J Santos, Joana Guedes, Diana Sequeira, João Miguel Marques Santos, Guiomar Oliveira, Ana Luísa Cardoso and 6 more

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ana Rafaela OliveiraCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Giuseppe CammarataCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Catarina SeabraCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Ana Maria CardosoCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Henrique J SantosCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.ORCID https://orcid.org/0009-0006-7108-125X
Joana GuedesCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.ORCID https://orcid.org/0000-0001-9054-1887
Diana SequeiraCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
João Miguel Marques SantosFaculty of Medicine, Institute of Endodontics, University of Coimbra, Coimbra, Portugal.
Guiomar OliveiraChild Developmental Centre and Centro de Investigação e Formação Clínica, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Ana Luísa CardosoCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Dominique FernandesCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Maria Isabel LeiteOxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Ester CoutinhoCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Ana Luísa CarvalhoCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.ORCID https://orcid.org/0000-0001-8368-6666
Lino FerreiraCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
João PeçaCNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.ORCID https://orcid.org/0000-0003-4989-2129

Funding

Bial Foundation 427/2024European Regional Development Fund (ERDF)European Union Horizon 2020 799164European Union Horizon 2020 813986Fundação para a Ciência e a Tecnologia 2022.02604.PTDCFundação para a Ciência e a Tecnologia FCT/NEURON/0002/2021Fundação para a Ciência e a Tecnologia PTDC/MED-NEU/5993/2020Fundação para a Ciência e a Tecnologia PTDC/NEU-SCC/3247/2014Programa Operacional Potencial Humano PD/BD/139074/2018Programa Operacional Potencial Humano SFRH/BPD/120611/2016
6 · The paper itself

Abstract

Gestational transfer of brain-reactive antibodies is a risk factor for neurodevelopmental disorders. Contactin-associated protein-like 2 (CASPR2) is a known target for pathogenic maternal autoantibodies which have been proposed to interfere with fetal neurodevelopment. However, the impact of CASPR2 antibodies on human brain development remains largely unknown. Here, to better understand the neurophysiological changes that occur in the presence of these pathogenic autoantibodies, we cultured unguided human neural organoids for a period of 6-months in media containing anti-CASPR2 antibodies. We then performed neurophysiological characterization via whole-cell patch-clamp and calcium imaging in acute organoid slices. Our results reveal that CASPR2 antibody exposure increased spontaneous synaptic activity, enhanced the maximal frequency of action potential firing and of spontaneous network activity. These findings are consistent with a state of neuronal hyperexcitability, a phenotype which is observed in several models of neurodevelopmental disorders. Mechanistically, the alterations observed in action potential waveform are in accordance with a role for CASPR2 in the regulation of voltage-gated potassium channels and a pathological role for CASPR2 autoantibodies in driving neuronal hyperexcitability.

Indexed as

AutoantibodiesBrainMembrane ProteinsNerve Tissue ProteinsNeuronsOrganoidsAction PotentialsFemaleHumansNeurodevelopmentAutoantibodiesCNTNAP2 protein, humanMembrane ProteinsNerve Tissue Proteinsautismbrain organoidsCASPR2electrophysiologyhyperexcitabilitymaternal autoantibodiesneurodevelopment

Identifiers

PMID41725505
PMCPMC12926859

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.